Italia markets open in 5 hours 16 minutes

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
112,94-4,19 (-3,58%)
Alla chiusura: 04:00PM EST
113,00 +0,06 (+0,05%)
Dopo ore: 07:59PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente117,13
Aperto116,22
Denaro112,73 x 800
Lettera113,00 x 1100
Min-Max giorno112,90 - 117,52
Intervallo di 52 settimane89,00 - 238,55
Volume2.338.832
Media Volume2.473.606
Capitalizzazione17,935B
Beta (5 anni mensile)1,09
Rapporto PE (ttm)N/D
EPS (ttm)-7,10
Prossima data utili05 feb 2024 - 09 feb 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A131,50
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera

  • GlobeNewswire

    Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

    Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industrySALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous rec